Hyun Chul Jung
Founder bei Beijing Sainuotai Biotechnology Co. Ltd.
Vermögen: 21 Mio $ am 31.03.2024
Profil
Hyun Chul Jung is the founder of Beijing Sainuotai Biotechnology Co. Ltd.
He currently holds a Director position at Immunotech Applied Science Ltd.
He previously served as the Chief Executive Officer & Director at Pharos Vaccine, Inc. and is currently the Executive Director & Chief Strategy Officer at Immunotech Biopharm Ltd.
Mr. Jung received his undergraduate and graduate degrees from Yonsei University in 1985 and 1987, respectively.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOTECH BIOPHARM LTD
8,71% | 11.04.2023 | 44 820 000 ( 8,71% ) | 21 Mio $ | 31.03.2024 |
Aktive Positionen von Hyun Chul Jung
| Unternehmen | Position | Beginn |
|---|---|---|
| Immunotech Applied Science Ltd. | Director/Board Member | 01.11.2006 |
| Beijing Sainuotai Biotechnology Co. Ltd. | Founder | - |
Ehemalige bekannte Positionen von Hyun Chul Jung
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Director/Board Member | 24.03.2023 |
Pharos Vaccine, Inc.
 Pharos Vaccine, Inc. BiotechnologyHealth Technology Pharos Vaccine, Inc. engages in research, development, and production of bio medicines such as vaccines and immune therapeutics. The company was founded on April 8, 2011 and is headquartered in Seongnam, South Korea. | Chief Executive Officer | 01.03.2019 |
Ausbildung von Hyun Chul Jung
| Yonsei University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOTECH BIOPHARM LTD | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Pharos Vaccine, Inc.
Pharos Vaccine, Inc. BiotechnologyHealth Technology Pharos Vaccine, Inc. engages in research, development, and production of bio medicines such as vaccines and immune therapeutics. The company was founded on April 8, 2011 and is headquartered in Seongnam, South Korea. | Health Technology |
| Immunotech Applied Science Ltd. | |
| Beijing Sainuotai Biotechnology Co. Ltd. |
